Atlas Venture Opportunity Fund I, L.P., 10% Owner at Kymera Therapeutics, Inc. (KYMR), sold 252,948 shares at $30.29 ($7.6M) on 2023-01-12, disclosed to the SEC on 2023-01-13.
Scheduled sale ($7.6M) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.96 | 6,071 | $182K | 2.4% |
| 2 | $29.96 | 6,071 | $182K | 2.4% |
| 3 | $29.96 | 21,683 | $650K | 8.5% |
| 4 | $29.96 | 21,683 | $650K | 8.5% |
| 5 | $30.29 | 21,592 | $654K | 8.6% |
| 6 | $30.29 | 21,592 |
| $654K |
| 8.6% |
| 7 | $30.29 | 77,128 | $2.3M | 30.6% |
| 8 | $30.29 | 77,128 | $2.3M | 30.6% |
| Total | $30.22 avg | 252,948 | $7.6M | 100% |
| Filing → |